2024/04/26 21:06:12 | |
---|---|
Price | |
883.585 USD | |
Difference | -0.80% (-7.10) |
ISIN | US75886F1075 |
Symbol | REGN |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 89,628 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 883.16 USD (400) |
Ask (Ask size) | 884.00 USD (200) |
Open | 881.72 USD |
High | 887.4794 USD |
Low | 875.225 USD |
Close (prev. day) | 890.68 USD |
VWAP | 882.036974 USD |
Volume (pcs) | 300,056 |
Trading volume | 264,698,783.27 |
Number of trades | 15,555 |
Last size | 100 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/04/26 | Global Equity Ratings | ||
2024/04/03 | Global Equity Ratings | ||
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings |
2024/04/26 21:06:12 | |
---|---|
Price | |
883.585 USD | |
Difference | -0.80% (-7.10) |
ISIN | US75886F1075 |
Symbol | REGN |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 89,628 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 883.16 USD (400) |
Ask (Ask size) | 884.00 USD (200) |
Open | 881.72 USD |
High | 887.4794 USD |
Low | 875.225 USD |
Close (prev. day) | 890.68 USD |
VWAP | 882.036974 USD |
Volume (pcs) | 300,056 |
Trading volume | 264,698,783.27 |
Number of trades | 15,555 |
Last size | 100 |
6m | 1Y | 3Y | |
Perf (%) | +11.75% | +12.80% | +82.28% |
Perf (abs.) | +93.64 | +101.10 | +402.04 |
Beta | 0.52 | 0.51 | 0.56 |
Volatility | 17.13 | 20.83 | 27.14 |
Ø price 5 days | Ø volume 5 days (pcs.) | 900.304 USD (430,067) |
Ø price 30 days | Ø volume 30 days (pcs.) | 936.346 USD (457,847) |
Ø price 100 days | Ø volume 100 days (pcs.) | 925.136 USD (520,174) |
Ø price 250 days | Ø volume 250 days (pcs.) | 840.281 USD (530,268) |
YTD High | date | 998.325 USD (2024/02/28) |
YTD Low | date | 871.390 USD (2024/01/02) |
52 Weeks High | date | 998.325 USD (2024/02/28) |
52 Weeks Low | date | 684.805 USD (2023/06/28) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/10/20 | 17:35 | 766.50 EUR | 0.09 | 18 |
Vienna Stock Exchange | 2024/04/26 | 17:32 | 827.00 EUR | 0.00 | 2 |
Tradegate | 2024/04/26 | 20:41 | 825.20 EUR | 0.02 | 8 |
Stuttgart | 2024/04/26 | 13:52 | 823.80 EUR | 0.02 | 4 |
Nasdaq | 2024/04/26 | 21:06 | 883.585 USD | 264.70 | 15,555 |
Munich | 2024/04/26 | 08:03 | 836.00 EUR | 0.00 | 1 |
London Stock Exchange | 2024/04/19 | 15:54 | 906.38 USD | 0.00 | 1 |
Hanover | 2024/04/26 | 08:05 | 829.00 EUR | 0.00 | 1 |
Hamburg | 2024/04/26 | 08:00 | 829.00 EUR | 0.00 | 1 |
Frankfurt | 2024/04/26 | 13:53 | 822.80 EUR | 0.00 | 2 |
Euronext Milan MTF Trading After Hours | 2024/03/06 | 18:32 | 895.00 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/04/26 | 17:44 | 825.60 EUR | 0.00 | 1 |
Duesseldorf | 2024/04/26 | 08:10 | 823.60 EUR | 0.00 | 1 |
Berlin | 2024/04/26 | 08:03 | 828.00 EUR | 0.00 | 1 |
REGENERON PHARMACEUTICALS INC. |
- - |
777 Old Saw Mill River Road - 10591-6707 Tarrytown |
Telefon: +1-914-847-7000 |
Fax: + |
E-mail: usinfo@regeneron.com |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY. |
George Yancopoulos | Chairman of Board of Directors |
Bonnie Bassler | Member of Board of Directors |
Craig Thompson | Member of Board of Directors |
David Schenkein | Member of Board of Directors |
Huda Zoghbi | Member of Board of Directors |
Joseph Goldstein | Member of Board of Directors |
Kathryn Guarini | Member of Board of Directors |
Michael Brown | Member of Board of Directors |
N. Coles | Member of Board of Directors |
Arthur Ryan | Member of Board of Directors |
Christine Poon | Member of Board of Directors |
George Sing | Member of Board of Directors |
Leonard S. Schleifer | Chairman of Managing Board |
George D. Yancopoulos | Member of Executive Committee |
Bob McCowan | Member of Executive Committee |
Joseph J. LaRosa | Member of Executive Committee |
Marion McCourt | Member of Executive Committee |
Melissa Lozner | Member of Executive Committee |
Robert E. Landry | Member of Executive Committee |
Sally A. Paull | Member of Executive Committee |
Smita Pillai | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer